Endoscopic Ultrasonography and Prognosis of Esophageal Cancer

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 6, 2006, Pages 695-700

  Das, Ananya ^a   Chak, Amitabh ^b   Sivak Jr , Michael V ^b   Payes, Jonathan ^b   Cooper, Gregory S ^b,c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; CLINICAL EXAMINATION; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CARCINOMA; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RACE DIFFERENCE; SEX RATIO; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; PROGNOSIS; SURVIVAL RATE;

EID: 33744757000     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.03.027     Document Type: Article

References (27)

1. Enzinger P.C., and Mayer R.J. Esophageal cancer. N Engl J Med 349 (2003) 2241-2252
2. Lightdale C.J., and Kulkarni K.G. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23 (2005) 4483-4489
3. Das A., and Chak A. Role of endoscopic ultrasonography in the staging of esophageal cancer. a review. Curr Opin Gastroenterol 19 (2003) 474-476
4. Harewood G.C., and Kumar K.S. Assessment of clinical impact of endoscopic ultrasound on esophageal cancer. J Gastroenterol Hepatol 19 (2004) 433-439
5. Harewood G.C., and Wiersema M.J. Cost minimization analysis of alternative strategies for initial staging of esophageal cancer. Gastrointest. Endosc 54 (2001) 2845
6. Potosky A.L., Riley G.F., Lubitz J.D., et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31 (1993) 732-748
7. Warren J.L., Klabunde C.N., Schrag D., et al. Overview of the SEER-Medicare data. content, research applications, and generalizability to the United States elderly population. Med Care 40 Suppl (2002) 3-18
8. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies. development and validation. J Chronic Dis 40 (1987) 373-383
9. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
10. Zhang M.J. Cox proportional hazards regression models for survival data in cancer research. Cancer Treat Res 113 (2002) 59-70
11. Chak A., and Cooper G.S. Procedure-specific outcomes assessment for endoscopic ultrasonography. Gastrointest Endosc Clin N Am 9 (1999) 649-656
12. Younes M., Henson D.E., Ertan A., et al. Incidence and survival trends of esophageal carcinoma in the United States. racial and gender differences by histological type. Scand J Gastroenterol 37 (2002) 1359-1365
13. Hiele M., De Leyn P., Schurmans P., et al. Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction. Gastrointest Endosc 45 (1997) 381-386
14. Christensen D. The Will Rogers phenomenon. roping the effects of a new cancer staging system. J Natl Cancer Inst 95 (2003) 1105-1106
15. Klabunde C.N., Warren J.L., and Legler J.M. Assessing co-morbidity using claims data. Med Care 40 Suppl (2002) IV-26-IV-35
16. Zhang J.X., Iwashyna T.J., and Christakis N.A. The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care 37 (1999) 1128-1139
17. Klabunde C.N., Potosky A.L., Legler J.M., et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 53 (2000) 1258-1267
18. Cooper G.S., Yuan Z., Stange K.C., et al. The sensitivity of Medicare claims data for case ascertainment of six common cancers. Med Care 37 (1999) 436-444
19. Javitt J.C., McBean A.M., Sastry S.S., et al. Accuracy of coding in Medicare Part B claims. cataract as a case study. Arch Ophthalmol 111 (1993) 605-607
20. Fisher E.S., Whaley F.S., Krushat W.M., et al. The accuracy of Medicare's hospital claims data. progress has been made, but problems remain. Am J Public Health 82 (1992) 243-248
21. Romano P.S., and Luft H.S. Getting the most out of messy data. problems and approaches for dealing with large administrative data sets. In: Grady M.L., and Schwartz H.A. (Eds). Medical effectiveness research data methods (1992), US Public Health Service, Rockville, MD
22. Cooper G.S., Chak A., Lloyd L.E., et al. The accuracy of diagnosis and procedural codes for patients with upper gastrointestinal hemorrhage. Gastrointest Endosc 51 (2000) 423-426
23. Cooper G.S., Yuan Z., Chak A., et al. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and cardia. Cancer 95 (2002) 32-38
24. Cooper G.S., Yuan Z., Stange K.C., et al. Agreement of Medicare claims and tumor registry data for assessment of cancer related treatment. Med Care 38 (2000) 411-421
25. Warren J.L., Harlan L.C., Fahey A., et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40 Suppl (2002) IV-55-IV-61
26. Enzinger P.C., and Mayer R.J. Gastrointestinal cancer in older patients. Semin Oncol 31 (2004) 206-219
27. Vazquez-Sequeiros E., Norton I.D., Clain J.E., et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 53 (2001) 751